Maprotiline

Suppliers

Names

[ CAS No. ]:
10262-69-8

[ Name ]:
Maprotiline

[Synonym ]:
3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine
Deprilept
Dibencycladine
N-methyl-9,10-ethanoanthracene-9(10H)-propanamine
Maprotilina
Maprotylina [Polish]
Maprotilinum
MFCD00661057
Maprotilin
Maprotilinum [INN-Latin]
EINECS 233-599-4
9-[3-(methylamino)propyl]-9,10-dihydro-9,10-ethanoanthracene
Maprotilina [INN-Spanish]
Maprotylina
[14C]-Maprotiline

Chemical & Physical Properties

[ Density]:
1.08 g/cm3

[ Boiling Point ]:
399.6ºC at 760 mmHg

[ Molecular Formula ]:
C20H23N

[ Molecular Weight ]:
277.40300

[ Flash Point ]:
187.7ºC

[ Exact Mass ]:
277.18300

[ PSA ]:
12.03000

[ LogP ]:
4.60230

[ Vapour Pressure ]:
1.35E-06mmHg at 25°C

[ Index of Refraction ]:
1.599

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KJ4552000
CHEMICAL NAME :
9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-
CAS REGISTRY NUMBER :
10262-69-8
LAST UPDATED :
199612
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C20-H23-N
MOLECULAR WEIGHT :
277.44
WISWESSER LINE NOTATION :
L6 H666/GP 2AF P&&TTJ O3M1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
26 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - coma Vascular - BP elevation not characterized in autonomic section
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 2,260,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
760 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
REFERENCE :
HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
105 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
APPHAX Acta Poloniae Pharmaceutica. For English translation, see APPFAR. (Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937- Volume(issue)/page/year: 40,235,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
38 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
REFERENCE :
HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
660 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
REFERENCE :
HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
140 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
APPHAX Acta Poloniae Pharmaceutica. For English translation, see APPFAR. (Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937- Volume(issue)/page/year: 40,235,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
31 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness Behavioral - ataxia Behavioral - muscle contraction or spasticity
REFERENCE :
HEPHD2 Handbook of Experimental Pharmacology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.50- 1978- Volume(issue)/page/year: 55,527,1980 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5760 mg/kg/22W-I
TOXIC EFFECTS :
Cardiac - EKG changes not diagnostic of specified effects Related to Chronic Data - death
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 30,1709,1980
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
650 mg/kg/7W-I
TOXIC EFFECTS :
Cardiac - EKG changes not diagnostic of specified effects
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year: 51,43,1982

Safety Information

[ RIDADR ]:
3249

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

[ HS Code ]:
2921499090

Synthetic Route

Precursor & DownStream

Precursor

  • 3-[Dibenzo[b,e]bicyclo[2.2.2]octadienyl-(1)]-propionsaeure-methylamid
  • Anthrone
  • 3-[Dibenzo[b,e]bicyclo[2.2.2]octadienyl-(1)]-propionsaeure
  • 3-(9-Anthryl)propionic acid
  • 3-[Dibenzo[b,e]bicyclo[2.2.2]octadienyl-(1)]-propionsaeurechlorid

DownStream

Customs

[ HS Code ]: 2921499090

[ Summary ]:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%


Related Compounds

  • maprotiline-d3
  • N-Methylmaprotiline
  • Maprotiline Mesylate
  • Maprotiline, N-acetyl
  • Maprotiline Hydrochloride
  • Maprotiline-d5 hydrochloride
  • rac-(9H-fluoren-9-yl)methyl (3R,4R)-3-(hydroxymethyl)-4-propylpyrrolidine-1-carboxylate
  • (9H-fluoren-9-yl)methyl N-[1-(2-hydroxyethyl)cyclobutyl]-N-methylcarbamate
  • (9H-fluoren-9-yl)methyl N-[3-(2,2,2-trifluoro-1-hydroxyethyl)oxetan-3-yl]carbamate
  • (9H-fluoren-9-yl)methyl N-[4,4-difluoro-1-(2-hydroxyethyl)cyclohexyl]-N-methylcarbamate
  • 4-[1-(4,4-Dimethylcyclohexyl)ethyl]piperidine
  • (9H-fluoren-9-yl)methyl N-{7-hydroxy-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl}carbamate
  • (9H-fluoren-9-yl)methyl N-{[5-(hydroxymethyl)bicyclo[3.1.0]hexan-1-yl]methyl}carbamate
  • (9H-fluoren-9-yl)methyl N-[3-(3-hydroxy-1H-indazol-1-yl)propyl]carbamate
  • (9H-fluoren-9-yl)methyl 7'-hydroxy-6',7'-dihydrospiro[azetidine-3,5'-pyrrolo[1,2-a]imidazole]-1-carboxylate
  • (9H-fluoren-9-yl)methyl N-{[1-(hydroxymethyl)-6-oxabicyclo[3.2.1]octan-5-yl]methyl}carbamate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.